Institutional Ownership Tango Therapeutics, Inc. (TNGX)
This table provides information about the institutional ownership of Tango Therapeutics, Inc. (TNGX). We have compiled data on the 138 institutions that hold shares in the stock, with a total of 91.1 Million shares, which have been reported (via 13F filing form) to have a value of $215 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Trv Gp Iv, LLC
Boston, MA |
Feb 13, 2025 Q4 2024 |
16,859,075
shares
|
$39.6 Million
64.97% of portfolio
|
Q3 2024
Reduced 12.2%
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
10,736,000
shares
|
$25.2 Million
5.42% of portfolio
|
Q4 2024
New holding
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
10,630,736
shares
|
$25 Million
1.53% of portfolio
|
Q4 2024
Reduced 20.25%
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
5,533,980
shares
|
$13 Million
3.19% of portfolio
|
Q3 2023
New holding
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,000,000
shares
|
$9.4 Million
0.07% of portfolio
|
Q4 2024
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,987,852
shares
|
$9.37 Million
0.0% of portfolio
|
Q2 2024
Added 3.28%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,985,225
shares
|
$9.37 Million
0.0% of portfolio
|
Q4 2024
Added 9.32%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,345,551
shares
|
$7.86 Million
0.01% of portfolio
|
Q4 2024
Reduced 33.4%
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,279,196
shares
|
$7.71 Million
0.02% of portfolio
|
Q4 2024
Added 22.03%
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Feb 14, 2025 Q4 2024 |
2,804,410
shares
|
$6.59 Million
0.44% of portfolio
|
Q4 2024
New holding
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,712,008
shares
|
$6.37 Million
2.26% of portfolio
|
Q3 2024
Reduced 6.25%
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
2,603,897
shares
|
$6.12 Million
0.36% of portfolio
|
Q3 2024
New holding
|
|
Blue Owl Capital Holdings LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,732,152
shares
|
$4.07 Million
2.29% of portfolio
|
Q4 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,626,759
shares
|
$3.82 Million
0.0% of portfolio
|
Q4 2024
Reduced 39.62%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,386,449
shares
|
$3.26 Million
0.0% of portfolio
|
Q4 2024
Added 1.33%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,231,199
shares
|
$2.89 Million
0.0% of portfolio
|
Q4 2024
Reduced 46.89%
|
|
Casdin Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,188,349
shares
|
$2.79 Million
0.32% of portfolio
|
Q4 2023
Reduced 9.1%
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Feb 14, 2025 Q4 2024 |
708,385
shares
|
$1.66 Million
0.03% of portfolio
|
Q4 2023
New holding
|
|
Bessemer Group Inc
Woodbridge, NJ |
Feb 13, 2025 Q4 2024 |
708,384
shares
|
$1.66 Million
0.0% of portfolio
|
Q2 2022
New holding
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
662,776
shares
|
$1.56 Million
0.0% of portfolio
|
Q4 2024
Added 83.75%
|
|
Schroder Investment Management Group
London, X0 |
Feb 12, 2025 Q4 2024 |
655,158
shares
|
$1.54 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
630,000
shares
|
$1.48 Million
0.6% of portfolio
|
Q1 2023
New holding
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
550,000
shares
|
$1.29 Million
0.05% of portfolio
|
Q4 2024
New holding
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
517,426
shares
|
$1.22 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
513,429
shares
|
$1.21 Million
0.0% of portfolio
|
Q4 2024
Added 5.38%
|